Interclean Shanghai

Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

FDA Widens Early Alert Initiatives for...

The Food and Drug Administration (FDA) has gone on to...

First U.S.-Based Experience Center of Siemens...

Siemens Healthineers has gone ahead and launched its first...

In view of the large outbreaks of infection by Acinetobacter baumannii and Pseudomonas aeruginosa, researchers sought to determine risk factors for the occurrence and appropriate infection control measures.

They observed that Acinetobacter outbreaks were mainly reported from intensive care units, after use of antibiotics and during mechanical ventilation. Outbreaks caused by P. aeruginosa affected intensive care units (ICUs) and peripheral wards equally.

In Acinetobacter outbreaks, mortality was twice as high as in Pseudomonas outbreaks. The mortality rates were not influenced by resistance profiles of either pathogen. These findings should support staff in Infection Control Departments and on wards if an outbreak is suspected.

They here suggested the necessity for better adherence to the Outbreak Reports and Intervention Studies of Nosocomial Infection guidelines in outbreak reporting.

Latest stories

Related stories

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

FDA Widens Early Alert Initiatives for All Medical Devices

The Food and Drug Administration (FDA) has gone on to...

First U.S.-Based Experience Center of Siemens Healthineers

Siemens Healthineers has gone ahead and launched its first...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »